Ken Tajima
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Interleukin-1α-Mediated Activation of TNF-α/NF-κB Signaling Confers Resistance to Osimertinib in EGFR-Mutant Non-Small-Cell Lung Cancer.
Journal: Thoracic cancer
Published: March 14, 2026
Challenges in the Development of Novel Therapies for Thoracic Malignancies.
Journal: Juntendo medical journal
Published: May 27, 2025
Second malignancy in advanced or recurrent non-small cell lung cancer after the advent of molecular targeted drugs and immunotherapy.
Journal: Thoracic cancer
Published: June 03, 2024
Clinical potential of SKP2 as diagnostic marker and therapeutic target in small cell lung cancer.
Journal: Respiratory investigation
Published: January 17, 2024
Anti-Müllerian hormone type II receptor protein expression in non-small cell lung cancer and the effect of AMH/AMHR2 signaling on cancer cell proliferation.
Journal: Thoracic cancer
Published: December 24, 2023
Trophoblast Cell Surface Antigen 2 Expression in Thymic Carcinoma: Brief Report.
Journal: JTO clinical and research reports
Published: December 22, 2023
Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines.
Journal: Cancers
Published: January 07, 2023
Comparison of ASCL1, NEUROD1, and POU2F3 expression in surgically resected specimens, paired tissue microarrays, and lymph node metastases in small cell lung carcinoma.
Journal: Histopathology
Published: September 28, 2022
Successful restart of chemotherapy in a patient with primary mediastinal nonseminomatous germ cell tumor after COVID-19 infection.
Journal: Thoracic cancer
Published: June 08, 2022
Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer-is there a "tail plateau" in the survival curve of these patients?
Journal: BMC cancer
Published: October 18, 2021
Last Updated: 09/26/2026